AbCellera Biologics (ABCL)
NASDAQ:ABCL

AbCellera Biologics (ABCL) Technical Analysis

1,442 Followers

Technical Sentiment

Overall Consensus
Sell
6Bullish
6Neutral
10Bearish
Technical Analysis Consensus
Neutral
2Bullish
6Neutral
2Bearish
Moving Average Consensus
Sell
4Bullish
0Neutral
8Bearish
AbCellera Biologics’s (ABCL) Moving Averages Convergence Divergence (MACD) indicator is -0.04, suggesting AbCellera Biologics is a Sell.
AbCellera Biologics’s (ABCL) 20-Day exponential moving average is 3.08, while AbCellera Biologics’s (ABCL) share price is $3.085, making it a Buy.
AbCellera Biologics’s (ABCL) 50-Day exponential moving average is 3.33, while AbCellera Biologics’s (ABCL) share price is $3.085, making it a Sell.

AbCellera Biologics (ABCL) Pivot Points

Jul 24, 2024, 04:48 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
2.86
2.90
2.95
2.99
3.04
3.08
3.13
Fibonacci
2.90
2.93
2.95
2.99
3.02
3.04
3.08
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

AbCellera Biologics (ABCL) Moving Averages

Jul 24, 2024, 04:48 PM
Period
Simple
Exponential
MA5
3.10Sell
3.09Buy
MA10
3.13Sell
3.08Buy
MA20
2.96Buy
3.08Buy
MA50
3.35Sell
3.33Sell
MA100
3.86Sell
3.75Sell
MA200
4.38Sell
4.30Sell
AbCellera Biologics’s (ABCL) 10-Day exponential moving average is 3.08, while AbCellera Biologics’s (ABCL) share price is $3.085, making it a Buy.
AbCellera Biologics’s (ABCL) 100-Day exponential moving average is 3.75, while AbCellera Biologics’s (ABCL) share price is $3.085, making it a Sell.
AbCellera Biologics’s (ABCL) stock price is $3.085 and AbCellera Biologics’s (ABCL) 50-day simple moving average is 3.35, creating a Sell signal.
AbCellera Biologics’s (ABCL) stock price is $3.085 and AbCellera Biologics’s (ABCL) 100-day simple moving average is 3.86, creating a Sell signal.
AbCellera Biologics’s (ABCL) stock price is $3.085 and AbCellera Biologics’s (ABCL) 200-day simple moving average is 4.38, creating a Sell signal.

AbCellera Biologics (ABCL) Technical Indicators

Jul 24, 2024, 04:48 PM
Name
Value
Implied Action
RSI (14)
49.24
Neutral
STOCH (9,6)
32.14
Neutral
STOCHRSI (14)
39.65
Neutral
MACD (12,26)
-0.04
Sell
ADX (14)
21.26
Neutral
Williams %R
-52.63
Buy
CCI (14)
40.27
Neutral
ATR (14)
0.19
-
Ultimate Oscillator
47.91
Neutral
ROC
11.91
Buy
AbCellera Biologics’s (ABCL) Relative Strength Index (RSI) is 49.24, creating a Neutral signal.
AbCellera Biologics’s (ABCL) Trend Strength Indicator (ADX) is 21.26, creating a Neutral signal.
AbCellera Biologics’s (ABCL) Commodity Channel Index (CCI) is 40.27, creating a Neutral signal.
AbCellera Biologics’s (ABCL) Price Rate of Change (ROC) is 11.91, creating a Buy signal.

FAQ

Is ABCL a Buy, Hold, or Sell?
Based on ABCL’s technical indicators, ABCL is a Sell.
    What is ABCL’s RSI (14)?
    ABCL’s RSI (14) is 49.24, which suggests ABCL is a Neutral.
      What is ABCL’s MACD?
      ABCL’s MACD is -0.04, which suggests ABCL is a Sell.
        What is ABCL’s 5-day moving average?
        ABCL’s 5-day moving average is 3.10, which suggests ABCL is a Sell.
          What is ABCL’s 20-day moving average?
          ABCL 20-day moving average is 2.96, which suggests ABCL is a Buy.
            What is ABCL’s 50-day moving average?
            ABCL’s 50-day moving average is 3.35, which suggests ABCL is a Sell.
              What is ABCL’s 200-day moving average?
              ABCL’s 200-day moving average is 4.38, which suggests ABCL is a Sell.
                What is ABCL’s Williams % R (14)?
                ABCL’s Williams % R (14) is -52.63, which suggests ABCL is a Buy.
                  What is ABCL’s CCI (14)?
                  ABCL’s CCI (14) is 40.27, which suggests ABCL is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis